
Iomai Corporation
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called.
Employees
Enterprise value
$216—324m
Authorizing premium user...
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called.